07/13/2026 12:32
Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T)

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that the U.S. Food & Drug Administration (FDA) granted Rare Pediatric Disease (RPD) Designation for its proprietary lead small molecule drug candidate NB4168 for the treatment of Ataxia Telangiectasia (A-T). NB4168 is an oral small molecule therapy engineered to deliver substantially greater nicotinamide riboside (NR) exposure...

07/14/2026 11:50
SLB, Liberty Energy to Form Strategic Alliance for Data Center Infrastructure and Power

Global energy technology company SLB (NYSE: SLB) today announced an agreement with Liberty Energy Inc. (NYSE: LBRT) to form a strategic alliance that will deliver modular infrastructure and integrated power generation solutions for new data center projects globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260714708557/en/A rendering of modular data center infrastructure with co-located, behind-the-meter generation. The collab...

06/30/2026 13:30
Andersen Global Adds Depth to Tax and Global Mobility Capabilities in Germany

Andersen Global strengthens its presence through a Collaboration Agreement with Lohr and Company (L+C), a senior-led tax advisory platform, providing practical, responsive solutions in tax compliance, cross-border tax, global mobility, and transfer pricing. Headquartered in Germany with a presence in Austria, L+C advises large multinationals and family-owned companies, family offices, foundations, and high-net-worth individuals. The firm, founded in 2001, specializes in areas such as global m...

06/22/2026 09:23
Europe’s Original First Check Investor Seedcamp Raises $320 Million

Seedcamp, Europe’s original first check investor and earliest backer of companies including Revolut, Wise, UiPath, Synthesia and Fluidstack, has raised $320 million to invest in the next generation of global companies. US expansion for born global founders and early growth capital for portfolio winners Since launching in 2007 with a $2.5m first fund, Seedcamp now manages over $1bn in AUM and has delivered some of the strongest venture fund returns in Europe. Seedcamp Fund III has now return...

06/30/2026 14:00
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS

Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and acces...

06/30/2026 14:13
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost

For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and prop...

06/30/2026 14:08
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™

Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an In...

David Millikin appointed North America Sales and Marketing Director

Brings long North America experience to developing AFP’s regional business.

Brings long North America experience to developing AFP’s regional business.
Anglais
07/14/2026 04:30
AV Access Unveils AnyCo V100 All-in-One 4K Conference Video Bar for Simpler and Smarter One-Cable Meetings

AV Access, a leading Pro AV provider, today introduced the AnyCo V100 all-in-one 4K conference video bar. Designed for small meeting spaces and huddle rooms, the AnyCo V100 streamlines hybrid work by combining video conferencing, presentation capabilities, 4K AI camera, speakerphones, laptop charging, and network connectivity into a single device. The product will be officially showcased at the InfoComm Asia 2026 exhibition starting tomorrow. One-Cable Plug-and-Play Video Conferencing and Pre...

07/14/2026 07:58
Swiss Pension Funds Increase Commitments to Record Infrastructure Equity Fund to EUR 1.23 Billion

Record Asset Management GmbH (RAM), subsidiary of London-listed Record plc (Record Financial Group), today announced that its Infrastructure Equity fund has attracted EUR 160 million of additional capital from Swiss pension funds, increasing total commitments to approximately EUR 1.23 billion. Capital deployment continues to progress in line with expectations, with more than one-third of the fund’s initial capital now deployed or committed to investments. This press release features multimedia...